RESUMO
The chondrodysplasias are a heterogeneous group of disorders characterized by abnormal growth or development of cartilage. Current classification is based on mode of inheritance as well as clinical, histologic, and/or radiographic features. A clinical spectrum of chondrodysplasia phenotypes, ranging from mild to perinatal lethal, is due to defects in the gene for type II collagen, COL2A1. This spectrum includes Stickler syndrome, Kniest dysplasia, spondyloepiphyseal dysplasia congenita (SEDC), achondrogenesis type II, and hypochondrogenesis. Individuals affected with these disorders exhibit abnormalities of the growth plate, nucleus pulposus, and vitreous humor, which are tissues that contain type II collagen. The Strudwick type of spondyloepimetaphyseal dysplasia (SEMD) is characterized by disproportionate short stature, pectus carinatum, and scoliosis, as well as dappled metaphyses (which are not seen in SEDC). The phenotype was first described by Murdoch and Walker in 1969, and a series of 14 patients was later reported by Anderson et al. The observation of two affected sibs born to unaffected parents led to the classification of SEMD Strudwick as an autosomal recessive disorder. We now describe the biochemical characterization of defects in alpha 1(II) collagen in three unrelated individuals with SEMD Strudwick, each of which is due to heterozygosity for a unique mutation in COL2A1. Our data support the hypothesis that some cases, if not all cases, of this distinctive chondrodysplasia result from dominant mutations in COL2A1, thus expanding the clinical spectrum of phenotypes associated with this gene.
Assuntos
Colágeno/genética , Genes Dominantes , Osteocondrodisplasias/genética , Adulto , Sequência de Bases , Criança , Colágeno/classificação , Cisteína , Análise Mutacional de DNA , DNA Complementar/genética , Feminino , Glicina , Humanos , Recém-Nascido , Masculino , Dados de Sequência Molecular , Osteocondrodisplasias/classificação , Linhagem , Fenótipo , Mutação PuntualRESUMO
Spondyloepiphyseal dysplasia tarda (SEDL; MIM 313400) is an X-linked recessive osteochondrodysplasia that occurs in approximately two of every one million people. This progressive skeletal disorder which manifests in childhood is characterized by disproportionate short stature with short neck and trunk, barrel chest and absence of systemic complications. Distinctive radiological signs are platyspondyly with hump-shaped central and posterior portions, narrow disc spaces, and mild to moderate epiphyseal dysplasia. The latter usually leads to premature secondary osteoarthritis often requiring hip arthroplasty. Obligate female carriers are generally clinically and radiographically indistinguishable from the general population, although some cases have phenotypic changes consistent with expression of the gene defect. The SEDL gene has been localized to Xp22 (refs 8,9) in the approximately 2-Mb interval between DXS16 and DXS987 (ref. 10). Here we confirm and refine this localization to an interval of less than 170 kb by critical recombination events at DXS16 and AFMa124wc1 in two families. In one candidate gene we detected three dinucleotide deletions in three Australian families which effect frameshifts causing premature stop codons. The gene designated SEDL is transcribed as a 2.8-kb transcript in many tissues including fetal cartilage. SEDL encodes a 140 amino acid protein with a putative role in endoplasmic reticulum (ER)-to-Golgi vesicular transport.
Assuntos
Proteínas de Transporte/genética , Proteínas de Membrana Transportadoras , Osteocondrodisplasias/genética , Cromossomo X , Adolescente , Adulto , Sequência de Aminoácidos , Sequência de Bases , Feminino , Ligação Genética , Heterozigoto , Humanos , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Mutação , Linhagem , Homologia de Sequência de Aminoácidos , Distribuição Tecidual , Fatores de TranscriçãoRESUMO
OBJECTIVE: The member of the tumor necrosis factor family LIGHT (lymphotoxin-like inducible protein that competes with glycoprotein D for herpesvirus entry on T cells; TNFSF14 (tumor necrosis factor super family protein 14) is primarily expressed in lymphocytes, in which it induces the expression of pro-inflammatory cytokines and alterations of lipid homeostasis. Recently, the protein was shown to be upregulated in obesity and to induce cytokine secretion from adipocytes. RESEARCH METHODS AND PROCEDURES: Using an automated complementary DNA (cDNA) screen, LIGHT was identified to inhibit adipose differentiation. As cellular models for adipogenesis mouse 3T3-L1, human SGBS (Simpson-Golabi-Behmel syndrome) and primary human preadipocytes differentiated in vitro were used as well as primary human adipocytes to study adipocyte functions. Analysis of lipid deposition by Oil Red O staining, mRNA expression by quantitative reverse transcriptase-PCR, nuclear factor (NF)-κB activation as well as protein secretion by enzyme linked immunosorbent assay and Luminex technology was performed. RESULTS: LIGHT was found to inhibit lipid accumulation in the three models of preadipocytes in a dose-dependent manner without cytotoxic effects. This inhibition of differentiation was probably because of interference at early steps of adipogenesis, as early exposure during differentiation showed the strongest effect, as assessed by decreased peroxisome proliferator-activated receptor-γ (PPARγ) and CCAAT/enhancer-binding protein-α (C/EBPα) mRNA expression. In contrast to TNFα, basal and insulin-stimulated glucose uptake and lipolysis of terminally differentiated mature adipocytes were not altered in the presence of LIGHT. At a concentration sufficient to inhibit differentiation, secretion of proinflammatory cytokines was not significantly induced and NF-κB activity was only modestly induced compared with TNFα. CONCLUSION: LIGHT is a novel inhibitor of human adipocyte differentiation without adversely influencing central metabolic pathways in adipocytes.
Assuntos
Adipócitos/efeitos dos fármacos , Glucose/metabolismo , Obesidade/metabolismo , Membro 14 da Superfamília de Ligantes de Fatores de Necrose Tumoral/metabolismo , Adipócitos/metabolismo , Adipogenia/efeitos dos fármacos , Animais , Diferenciação Celular/efeitos dos fármacos , Citocinas/metabolismo , Humanos , Interleucina-6/metabolismo , Metabolismo dos Lipídeos/efeitos dos fármacos , Camundongos , NF-kappa B/genética , NF-kappa B/metabolismo , Obesidade/genética , Membro 14 da Superfamília de Ligantes de Fatores de Necrose Tumoral/genéticaRESUMO
The Internet is an increasingly important source of health-related information. However, the growth of the Internet and its use as a medical delivery tool should be viewed with caution. One of the key concerns is that although the volume of information is huge, the quality, accuracy and completeness of the information is questionable. The aim of this study was to evaluate burns first aid information on the Internet. The search term used was "first aid for burns" and the first 25 hits from each search engine were analysed by one of the observers. We gathered basic information on the web sites--such as the country of origin, language in which the information was offered, accessibility, relevance and whether the site was commercial, organisational or academic. Quality and technicality of the web sites were assessed and scored. The mean quality score was 4.7/15 (31.5%) The mean technical score was 6.1 of 12 (51.1%). When the total score was categorised by percentage, none of the web sites ranked in the excellent category, 1 was very good, 4 were good, 6 were fair and the majority, 36, were poor. Based on the quality score only, two web sites were in the excellent category and two were very good. For technicality one web site was excellent and three were very good. This study has shown first aid information on the Internet is largely of poor quality, that the technical information provided is inadequate and that the sites include a significant amount of grossly inaccurate information. The few sites that contain excellent technical information make up a very small proportion of what is available. Therefore, the average Internet user may not encounter these resources, instead gaining knowledge from sites of questionable value.
Assuntos
Queimaduras/terapia , Primeiros Socorros/normas , Internet/normas , Informática Médica/normas , Primeiros Socorros/métodos , Humanos , Armazenamento e Recuperação da Informação/métodos , Armazenamento e Recuperação da Informação/normas , Informática Médica/métodosRESUMO
A previous report (Watkins, M.S., Hitt, A.S. and Bulger, J.E. (1977) Biochem. Biophys. Res. Commun. 79, 640-647) has indicated that the asymmetric forms of Electrophorus acetylcholinesterase bind exclusively to sphingomyelin vesicles through interaction with the collagen-like 'tail' portion of the enzyme. We report here that acetylcholinesterase also binds to phosphatidylcholine vesicles containing saturated fatty acyl chains and to egg phosphatidylcholine vesicles containing cholesterol. This suggests preferential binding of acetylcholinesterase to membranes of lower fluidity. Surface charge of vesicles and density of zwitterionic lipid headgroups do not significantly affect binding of native acetylcholinesterase. The presence of chondroitin sulfate or hyaluronic acid slightly increases the binding of native acetylcholinesterase to sphingomyelin vesicles, while the presence of 1 M NaCl, bovine serum albumin, or tissue fractions enriched in basement membrane diminish binding. The dissociation constant for native acetylcholinesterase and sphingomyelin vesicles is (1.0-1.5) X 10(-7) M, as measured by a flotation binding assay. The globular, 11S form of acetylcholinesterase also binds to lipid vesicles, although not to the same degree as native acetylcholinesterase. This suggests that the collagen tail of the enzyme enhances binding, but is not essential for binding to occur. These results are consistent with the location of acetylcholinesterase on the surface of the postsynaptic plasma membrane in vivo.
Assuntos
Acetilcolinesterase/metabolismo , Bicamadas Lipídicas/metabolismo , Fluidez de Membrana , Animais , Bovinos , Centrifugação com Gradiente de Concentração , Sulfatos de Condroitina/metabolismo , Órgão Elétrico/enzimologia , Electrophorus , Cinética , Esfingomielinas/metabolismoRESUMO
We have developed a simple method for the synthesis of the ligand 9-(5-carboxypentylamino)-acridine and the resulting affinity adsorbent using Sepharose CL-4B. This affinity adsorbent is efficient and specific for purification acetylcholinesterase (acetylcholine acetylhydrolase, EC 3.1.1.7) from Electrophorus electricus electric organ.
Assuntos
Acetilcolinesterase/isolamento & purificação , Aminoacridinas/síntese química , Electrophorus/metabolismo , Marcadores de Afinidade/síntese química , Animais , Cromatografia de Afinidade/métodosRESUMO
PTPN11 gene mutations are common to both patients with Noonan (NS) and LEOPARD syndrome (LS). So far only two recurrent mutations have been identified in LS patients by different research groups, i.e., Tyr279Cys and Thr468Met. In this work we describe the third PTPN11 mutation that has been found in a single LS patient. The mutation (c.1517A>C) substitutes a proline for a glutamine at amino acid 506 (Gln506Pro) in the phosphatase domain (PTP) of the PTPN11 peptide SHP2. This region is a mutation hotspot. Changes at amino acids 501 to 504 cause NS. Gln506Pro is predicted, by modeling analysis, to seriously disrupt the normal contacts between the regulating N-SH2 and the active PTP domains, leading to hyperactivity of the phosphatase. This report demonstrates that rarer mutations other than Tyr279Cys and Thr468Met can be found in LS patients and the need of screening the whole gene in those negative for the commonest mutations.
Assuntos
Síndrome LEOPARD/genética , Mutação de Sentido Incorreto , Proteínas Tirosina Fosfatases/genética , Adulto , DNA/química , DNA/genética , Análise Mutacional de DNA , Humanos , Peptídeos e Proteínas de Sinalização Intracelular , Síndrome LEOPARD/patologia , Masculino , Modelos Moleculares , Polimorfismo Conformacional de Fita Simples , Estrutura Terciária de Proteína/genética , Proteína Tirosina Fosfatase não Receptora Tipo 11 , Proteínas Tirosina Fosfatases/químicaRESUMO
The Drosophila melanogaster white gene is a member of the ABC transporter superfamily of ATPase transmembrane proteins and is involved in the cellular uptake of guanine and tryptophan. We have cloned and sequenced human and mouse homologs of white which share 55-58% amino acid similarity with the Drosophila protein. Northern analysis reveals that the mammalian homolog is highly expressed in several tissues, including brain, spleen, lung and placenta. We have localized the gene to human chromosome 21q22.3 by means of fluorescence in situ hybridization and linkage analysis using a (CA)n polymorphism. The human homolog maps to the interval between D21S212 and D21S171, a region which includes loci for bipolar affective disorder and a recessive form of deafness. Since tryptophan is a precursor for the neurotransmitter serotonin and neurotoxic metabolites of the kynurenine pathway, we propose that the human homolog of white is a suitable candidate gene for these neurological disorders in humans.
Assuntos
Transportadores de Cassetes de Ligação de ATP/genética , Sequência de Aminoácidos , Animais , Northern Blotting , Encéfalo/metabolismo , Mapeamento Cromossômico , Cromossomos Humanos Par 21 , Clonagem Molecular , DNA Complementar/genética , Drosophila melanogaster/genética , Fibroblastos , Regulação da Expressão Gênica , Ligação Genética , Humanos , Hibridização In Situ , Pulmão/metabolismo , Camundongos , Dados de Sequência Molecular , Placenta/metabolismo , Polimorfismo Genético , RNA/análise , Alinhamento de Sequência , Homologia de Sequência de Aminoácidos , Baço/metabolismoRESUMO
We report on an African-American patient with alopecia universalis, microcephaly, hypogonadism, and mental and growth retardation, and compare his phenotype to others with recessive alopecia/mental retardation syndromes in the literature. Our patient represents the first case reported from nonconsanguineous African-American parents.
Assuntos
Alopecia/genética , Deficiência Intelectual/genética , População Negra , Pré-Escolar , Feminino , Humanos , Hipogonadismo/genética , Recém-Nascido , Masculino , Microcefalia/genética , Gravidez , SíndromeRESUMO
We describe identical twin sisters born to nonconsanguineous, healthy parents. Both twins had situs viscerum inversus and developed hypertrophic cardiomyopathy in adulthood.
Assuntos
Cardiomiopatia Hipertrófica , Doenças em Gêmeos , Situs Inversus , Adulto , Idade de Início , Cardiomiopatia Hipertrófica/etiologia , Cardiomiopatia Hipertrófica/fisiopatologia , Dextrocardia/etiologia , Feminino , Humanos , Situs Inversus/complicações , Situs Inversus/fisiopatologia , Gêmeos MonozigóticosRESUMO
We describe a premature male infant with a terminal deletion of 7q [del(7) (pter----q34:)]. Manifestations include low birth weight, hypertelorism, bilateral cleft lip and palate, cryptorchidism, and a complex congenital heart defect. The latter consisted of hypoplasia of the main pulmonary artery, absent pulmonary valve, ventricular septal defect, and anomalous right pulmonary artery. We briefly review the spectrum of heart defects seen with chromosome 7 deletions, and comment on the incidence of this unusual heart lesion.
Assuntos
Aberrações Cromossômicas/complicações , Cromossomos Humanos Par 7 , Cardiopatias Congênitas/genética , Bandeamento Cromossômico , Deleção Cromossômica , Transtornos Cromossômicos , Mapeamento Cromossômico , Fenda Labial/genética , Fissura Palatina/genética , Humanos , MasculinoRESUMO
A prospective trial was conducted including 300 pregnant women seeking elective abortion to evaluate the safety and efficacy of methotrexate and misoprostol for abortion at < or = 56 days gestation. Subjects received methotrexate 50 mg/ m2 intramuscularly followed 7 days later by misoprostol 800 micrograms vaginally. The misoprostol dose was repeated the next day if the abortion did not occur. Outcome measures included successful abortion (complete abortion without requiring a surgical procedure), duration of vaginal bleeding, and side effects. Complete abortion occurred in 263/ 300 (87.7%, 95% CI 83.4, 91.2%) patients. The complete abortion rate was higher for early gestations: 183/202 (90.6%, 95% CI 85.7, 94.2%) at < or = 49 days gestation, and 80/98 (81.6%, 95% CI 72.5, 88.7%) from 50-56 days gestation (p = 0.038). Abortion occurred in the 24 hours following the initial or repeat misoprostol dose (immediate success) in 65.0%; the remaining 22.7% of women who aborted did so after a delay of 23.6 +/- 9.1 (mean +/- standard deviation) days. Vaginal bleeding lasted 14 +/- 7 days and 11 +/- 9 days in immediate success and delayed success patients, respectively. Overall, 69.7%, 87.7%, and 91.7% of patients had passed the pregnancy by 14, 28, and 35 days, respectively, after receiving methotrexate. Methotrexate and misoprostol side effects were minimal. This treatment regimen offers an alternative to surgical abortion or the use of antiprogestins and prostaglandin for medical abortion.
PIP: Clinical researchers recruited 300 healthy English- and Spanish-speaking pregnant women of gestational age no greater than 56 days for a prospective clinical trial of intramuscular 50 mg/sq. m methotrexate and 800 vaginal mcg misoprostol for induced abortion. The women were recruited from San Francisco General Hospital in California; Magee-Women's Hospital in Pittsburgh, Kansas; and Women's Health Care Services in Wichita, Kansas. 87.7% of the women had a complete abortion without need for a surgical procedure. After administration of methotrexate, passage of the conceptus increased as time passed (69.7% for 14 days, 87.7% for 28 days, and 91.7% for 35 days). The complete abortion rate decreased as the gestational age increased (90.6% for 49 days vs. 81.6% for 50-56 days; p = 0.038). Abortion took place within 24 hours of the first or repeat misoprostol dose in 65% of women who aborted. The success rate after the first dose of misoprostol was higher between 43 and 56 days than before 43 days (54.7% vs. 43.5%; p = 0.07). All women with an incomplete abortion experienced persistent and/or heavy vaginal bleeding. Vaginal bleeding lasted, on average, for 14 days in immediate success cases and for 11 days in delayed success cases. Multivariate logistic regression analysis found a significant predictor of success for the methotrexate and misoprostol combination to be gravidity under 3 (p = 0.01, odds ratio [OR] = 2.6). Serum beta-human chorionic gonadotropin of 40,000-80,000 IU/L (p = 0.025, OR = 0.38) and serum beta-human chorionic gonadotropin of 80,000 IU/L (p 0.001, OR = 0.2) were significant predictors of its failure. The rate of side effects was low. These findings show that this treatment regimen is a safe and effective alternative to surgical abortion or the use of antiprogestins and prostaglandins for medical abortion.
Assuntos
Abortivos não Esteroides/farmacologia , Aborto Induzido/métodos , Metotrexato/farmacologia , Misoprostol/farmacologia , Abortivos não Esteroides/administração & dosagem , Abortivos não Esteroides/efeitos adversos , Aborto Induzido/estatística & dados numéricos , Administração Intravaginal , Adulto , Gonadotropina Coriônica/sangue , Feminino , Humanos , Injeções Intramusculares , Metotrexato/administração & dosagem , Metotrexato/efeitos adversos , Misoprostol/administração & dosagem , Misoprostol/efeitos adversos , Razão de Chances , Paridade , Cooperação do Paciente , Gravidez , Resultado da Gravidez , Primeiro Trimestre da Gravidez , Estudos Prospectivos , Segurança , Inquéritos e QuestionáriosRESUMO
This article reviews the newly described biochemical (type I and II collagen) abnormalities and specific gene defects in the skeletal dysplasias. The model of the collagen molecule is described and how collagen is processed from procollagen, where and how abnormalities occur, and the types of abnormalities produced (quantitative and qualitative). The only known type I collagen defects producing skeletal dysplasias--osteogenesis imperfecta, as well as the 'family' of established type II collagen disorders--achondrogenesis type II, hypochondrogenesis and spondyloepiphyseal dysplasia congenita are discussed. Finally, using case presentations, the practical approach to these disorders is shown. The importance of these investigations and the subsequent reevaluation of the clinical and radiological findings of specifically delineated skeletal dysplasias are discussed.
Assuntos
Doenças do Desenvolvimento Ósseo/genética , Aberrações Cromossômicas/genética , Doenças do Colágeno/genética , Colágeno/genética , Adolescente , Doenças do Desenvolvimento Ósseo/metabolismo , Criança , Transtornos Cromossômicos , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Osteocondrodisplasias/genética , Osteogênese Imperfeita/genéticaAssuntos
Anormalidades Múltiplas/diagnóstico por imagem , Artrogripose/diagnóstico por imagem , Transtornos Cromossômicos/diagnóstico por imagem , Anormalidades Múltiplas/mortalidade , Aborto Induzido , Adulto , Artrogripose/mortalidade , Autopsia , Transtornos Cromossômicos/mortalidade , Feminino , Humanos , Gravidez , UltrassonografiaRESUMO
The gene for the alpha 1 (III) chain of type III collagen, COL3A1, has been previously mapped to human chromosome 2q24.3-q31 by in situ hybridization. Physical mapping by pulsed-field gel electrophoresis has demonstrated that COL3A1 lies within 35 kb of COL5A2. We genotyped the CEPH families at the COL3A1 locus using a pentanucleotide repeat polymorphism within intron 25. We demonstrated significant linkage to 18 anonymous markers as well as the gene for carbamyl phosphate synthetase (CPSI), which we have previously mapped to this region. No recombination was seen between COL3A1 and COL5A2 (Z = 9.93 at theta = 0) or D2S24 (Z = 10.55 at theta = 0). The locus order is (D2S32-D2S138-D2S148)--(D2S24-COL5A2-CO L3A1)--(D2S118-D2S161), with odds of 1:2300 for the next most likely order. These relationships are consistent with the physical mapping of COL3A1 to the distal portion of 2q and place it proximal to CPSI by means of multipoint analysis. These linkage relationships should prove useful in further studies of Ehlers-Danlos syndrome type IV and carbamyl phosphate synthetase I deficiency and provide an additional framework for localizing other genes in this region.
Assuntos
Cromossomos Humanos Par 2 , Colágeno/genética , Polimorfismo Genético , Sequências Repetitivas de Ácido Nucleico , Sequência de Bases , Mapeamento Cromossômico , DNA , Humanos , Dados de Sequência MolecularRESUMO
We have characterized a mutation in the type II collagen gene (COL2A1) that produces a form of spondyloepiphyseal dysplasia. The mutation is an internal tandem duplication of 45 base pairs within exon 48 and results in the addition of 15 amino acids to the triple-helical domain of the alpha 1 chains of type II collagen derived from the abnormal allele. Although the repeating (Gly-Xaa-Yaa)n motif that characterizes the triple-helical domain is preserved, type II collagen derived from cartilage of the affected individual contains a population with excessive posttranslational modification, consistent with a disruption in triple-helix structure. The mutation is not carried by either parent, indicating that the phenotype in the affected individual is due to a new dominant mutation. DNA sequence homology in the area of the duplication suggests that the mutation may have arisen by unequal crossover between related sequences, a proposed mechanism in the evolution and diversification of the collagen gene family.
Assuntos
Colágeno/genética , Éxons , Genes , Família Multigênica , Mutação , Osteocondrodisplasias/genética , Alelos , Sequência de Aminoácidos , Sequência de Bases , Criança , Clonagem Molecular , DNA/genética , Feminino , Humanos , Masculino , Dados de Sequência Molecular , Sondas de Oligonucleotídeos , Reação em Cadeia da PolimeraseRESUMO
We have identified five families in whom individuals affected with the Ehlers Danlos syndrome (EDS) types I, II or III had aortic root dilatation (ARD). All propositi had a low upper/lower segment ratio but no other diagnostic skeletal or ocular features of Marfan syndrome. Their skin had the soft, velvety texture characteristic of EDS and all had significant joint laxity. Probands included a 4-year-old girl with EDS type I, 4- and 8-year-old girls with EDS type III, a 35-year-old male with EDS type II, and a 51-year-old female with EDS type III. Review of these cases suggests the need for multicenter clinical studies in order to determine the prevalence and the rate of progression of ARD in EDS types I, II, and III. Such studies are necessary to determine whether echocardiograms (including measurement of aortic root diameter) should be considered on initial evaluation of all patients with mild forms of EDS.
Assuntos
Aorta/anormalidades , Síndrome de Ehlers-Danlos/patologia , Adulto , Criança , Pré-Escolar , Dilatação Patológica , Feminino , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
The ultraviolet-light absorption and fluorescence of Triton X-100 were virtually eliminated by hydrogenation to its reduced cyclohexyl analog, RTX-100. The critical micelle concentration of RTX-100 was 12% higher than that of Triton X-100. RTX-100 and Triton X-100 were quite similar in their abilities to extract proteins from human erythrocyte membranes.
Assuntos
Detergentes , Polietilenoglicóis , Tensoativos , Cromatografia em Camada Fina , Membrana Eritrocítica/análise , Humanos , Proteínas de Membrana/isolamento & purificação , Micelas , Octoxinol , Espectrometria de Fluorescência , Espectrofotometria UltravioletaRESUMO
Hexokinase II, one member of a family of structurally similar enzymes that catalyze the phosphorylation of glucose in the 6-position, has been suggested to play a role in the pathophysiology of noninsulin-dependent diabetes mellitus (NIDDM). The gene for hexokinase II, HK2, has been previously mapped to human chromosome 2p13 by fluorescence in situ hybridization, and two-point linkage analysis has placed it near the locus for transforming growth factor alpha, TGFA. We now report the characterization of a (TA)n polymorphism in intron 12 of HK2. Using multipoint analysis of CEPH family genotypes, we have determined the most likely locus order to be cen-D2S169-[D2S286-HK2]-[D2S145-D2S291]-[+ ++D2S45-D2S101-TGFA]-tel. As HKII is a candidate gene that could contribute to the manifestation of insulin resistance and NIDDM, we genotyped 1152 Pima Indians, a Native American tribe that has the highest reported prevalence of NIDDM in the world. Although we did not detect any linkage or association of HK2 with insulin resistance or NIDDM in the Pima Indians, the polymorphism and detailed mapping of HK2 described in this report should prove useful in the assessment of the role of this gene in the predisposition to NIDDM in other populations.
Assuntos
Diabetes Mellitus Tipo 2/genética , Hexoquinase/genética , Indígenas Norte-Americanos/genética , Polimorfismo Genético , Sequência de Bases , Ligação Genética , Humanos , Dados de Sequência MolecularRESUMO
Type IX collagen is a minor cartilage component which associates with mixed fibrils of types II/XI collagen. We have determined the precise physical and genetic locations for the gene encoding the alpha3 chain of type IX collagen, COL9A3. Utilizing fluorescence in situ hybridization, radiation hybrid mapping, and multipoint linkage analysis, we have mapped COL9A3 to human chromosome 20q13.3, 13 cM telomeric to D20S173.